BPI relies on continuity: Dr. Bernd Wegener confirmed as CEO

08.06.2011 14:13

The members of the Federal Association of the Pharmaceutical Industry (BPI) have elected their new board. In the office of chairman, Dr. Bernd Wegener (co.don AG), who has headed the association since 2000, confirmed.

“I am pleased about the trust the members of the BPI have once again placed in me. We are facing major challenges that we can only overcome together, as a strong association. With the election of three new young entrepreneurs to the board, the generational change continues,” explained Dr. Bernd Wegener after the election. Uwe Alter (B. Braun Melsungen AG), Dr. Dr. Richard Ammer (Medice Arzneimittel Pütter GmbH & Co. KG), Prof. Dr. Michael Habs (Dr. Willmar Schwabe GmbH & Co. KG) and Prof. Dr. Michael Popp (Bionorica SE) confirmed in office.